Enter assignee name

EPO Patents = 3

Trademarks = 1

Forward Citations = 20

Loading Chart...

12 inventors (with patents filed for the assignee):

Eduardo J Martinez (6 out of 22 patents)

Aniruddh Singh (3 out of 7 patents)

Sohail Tavazoie (3 out of 28 patents)

4. Padmini Kavuru (3 out of 6 patents)

5. Andreas G Grill (3 out of 3 patents)

6. Masoud Tavazoie (1 out of 9 patents)

7. Isabel Kurth (1 out of 4 patents)

8. Bernd Kaiser (1 out of 5 patents)

9. Foster Casimir Gonsalves (1 out of 6 patents)

10. David M Darst, Jr (1 out of 2 patents)

11. Nicholas D Paschalides (1 out of 6 patents)

12. Stephen A Wald (1 out of 1 patent)

13. Padmini Kavuru (5 patents)

14. Masoud Fakhr Tavazoie (0 patent)

6 patents: Sort by Forward Citations

1. 10717704 - Inhibitors of creatine transport and uses thereof (2020-07-21),

2. 10669296 - LXR agonists and uses thereof (2020-06-02),

3. 10512623 - Pharmaceutically acceptable salts of B-Guanidinopropionic acid with improved properties and uses thereof (2019-12-24),

4. 10308597 - Inhibitors of creatine transport and uses thereof (2019-06-04),

5. 9884813 - Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof (2018-02-06),

6. 9827217 - Pharmaceutically acceptable salts of B-guanidinopropionic acid with improved properties and uses thereof (2017-11-28),

Rgenix, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative cancer therapies. They specialize in identifying and targeting novel cancer pathways to create life-changing treatments for patients. With a diverse pipeline of drug candidates and a team of experienced researchers and executives, Rgenix is committed to advancing the field of oncology and improving outcomes for cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.